|
Volumn 44, Issue 8, 2009, Pages 453-455
|
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: A global perspective
a b c d e f g a h |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
CHICKENPOX VACCINE;
CIDOFOVIR;
IMMUNOSUPPRESSIVE AGENT;
ITRACONAZOLE;
MICAFUNGIN;
OSELTAMIVIR;
PNEUMOCOCCAL CONJUGATE VACCINE;
PNEUMOCOCCAL POLYSACCHARIDE VACCINE 23 VALENT;
PNEUMOCOCCUS VACCINE;
POSACONAZOLE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RITUXIMAB;
UNCLASSIFIED DRUG;
VALGANCICLOVIR;
VARICELLA ZOSTER VACCINE;
VORICONAZOLE;
ZANAMIVIR;
ALLOGENEIC STEM CELL TRANSPLANTATION;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BACTERIAL INFECTION;
CANDIDIASIS;
CHICKENPOX;
CYTOMEGALOVIRUS INFECTION;
DRUG CONTRAINDICATION;
EDITORIAL;
GRAFT RECIPIENT;
GRAFT VERSUS HOST REACTION;
HEALTH SERVICE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HIGH RISK PATIENT;
HOSPITAL INFECTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION;
INFECTION CONTROL;
INFLUENZA;
MYCOSIS;
MYELOABLATIVE CONDITIONING;
NEUTROPENIA;
OPPORTUNISTIC INFECTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SOCIAL SUPPORT;
VACCINATION;
VIRUS INFECTION;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
IMMUNOCOMPROMISED PATIENT;
IMMUNOLOGY;
EVIDENCE BASED MEDICINE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOCOMPROMISED HOST;
OPPORTUNISTIC INFECTIONS;
EVIDENCE-BASED MEDICINE;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 70350774376
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/bmt.2009.254 Document Type: Editorial |
Times cited : (301)
|
References (0)
|